Clinical Trial Update: Methylphendidate Treatment of Cocaine Dependent Patients With Attention Deficit Hyperactivity Disorder - 3 [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating methylphenidate for cocaine use disorder in patients with ADHD; the study conducted by NIDA is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Cocaine Use Disorder

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Cocaine-Related Disorders | Phase 2 | Status: COMPLETED